ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Jun 15, 2017 11:15 JST
Source:
Alset International Ltd
First-Year Performance of Global Systematic Multi-Strategy Fund
SINGAPORE, Jun 15, 2017 - (ACN Newswire) - The Board of Directors of Singapore eDevelopment Ltd ("SeD" or "the Group") wishes to announce that its Global Systematic Multi-Strategy Fund ("GSMS Fund") managed by Hengfai Asset Management Pte Ltd ("HFAM"), a wholly owned subsidiary of SeD's investment-arm SeD Capital Pte Ltd, achieved a gross and net return of 15% and 10%, respectively, in its first year of operation. The net returns are calculated by its fund administrator, Maples Fund Services.
Launched on 1 June 2016, the GSMS Fund adopts an "all-weather" strategy that seeks to produce consistent risk-adjusted returns regardless of market volatility. The GSMS Fund employs a systematic approach focusing on liquid exchange traded securities that are diversified across asset classes, geographical regions and time-frames.
HFAM intends to allow investors the option to receive 100% of the net profits (after all fees) on an annual basis or to reinvest all profits back into the fund. HFAM also intends to offer the GSMS Fund to global fund of funds.
HFAM is a registered fund management company regulated by the Monetary Authority of Singapore. As at the date of this announcement, HFAM manages two (2) live funds, namely, the GSMS Fund and Global Opportunity Fund. As announced by the Company on 15 May 2017, HFAM also intends to manage two (2) additional funds, namely, Global Property Development Fund and Global High Yield Income Fund. The Company will make subsequent announcements to update its shareholders when there are material updates as may be necessary or appropriate.
The acquisition of HFAM is part of the Group's efforts to develop new revenue streams and is in line with the Group's pursuit of providing capital services and creating opportunities to accelerate SeD's corporate recovery.
SeD website: www.sed.com.sg
HFAM website: www.hf-asset.com
About Singapore eDevelopment Limited
Incorporated on 9 September 2009 and listed on the Singapore Exchange Catalist (SGX:40V) in July 2010, Singapore eDevelopment Limited is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) Information Technology-related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities.
Issued on behalf of the Company:
WeR1 Consultants Pte Ltd
3 Phillip Street, #12-01, Royal Group Building
Singapore 048693
Mr Ian Lau
E:
ianlau@wer1.net
T: +65 6737 4844
Source: Alset International Ltd
Sectors: Funds & Equities
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Nissan, Honda and Mitsubishi Motors terminate MOU regarding consideration of tripartite collaboration
Feb 13, 2025 16:20 JST
ANA InterContinental Tokyo unveils Icon Reborn transformation
Feb 13, 2025 15:00 JST
MHI Thermal Systems Receives Top Honors on Australia's Foremost Consumer Review Platform for Two Series of Split System Air-Conditioners
Feb 13, 2025 12:47 JST
Honda Presents World Premiere of Seven Refreshed Large-size Outboard Motors at the Miami International Boat Show 2025
Feb 13, 2025 10:50 JST
Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management
Feb 13, 2025 10:01 JST
ULVAC Develops Roll-to-Roll Lithium Deposition System, Unveiling at Battery Japan
Feb 13, 2025 08:30 JST
Mitsubishi Power Secures Major Gas Turbine and Services Order for Al Wahda Open Cycle Gas Turbine Power Plant in Morocco
Feb 12, 2025 16:21 JST
MHI Delivers Final 7000-Series AGT Trainset for the Astram Line
Feb 12, 2025 12:24 JST
Fujitsu and Yokohama National University achieve world's first real-time prediction of tornadoes associated with typhoons using supercomputer Fugaku
Feb 12, 2025 11:37 JST
NEC Solution Modernizes Network Infrastructure Construction Work
Feb 10, 2025 15:05 JST
Olympus Recognized on CDP's "A List", the Highest Rating in the Field of Climate Change
Feb 10, 2025 11:00 JST
uSMART Capital, LLC officially approved for U.S. FINRA license
Feb 07, 2025 17:40 JST
TANAKA to Provide Medals for the Tokyo Marathon 2025 That Represent All the Participants in the Event with Woven Lines
Feb 07, 2025 04:00 JST
MHI Thermal Systems to Launch New Model of the "Ene-Conductor" Heat Source Control System
Feb 06, 2025 16:51 JST
Hitachi establishes its fourth Corporate Venture Capital Fund to capture technology turning points and future growth opportunities
Feb 06, 2025 16:32 JST
Approval in Principle (AiP) Acquired from Classification Society for Low-Pressure Type Coastal Liquefied CO2 Carrier
Feb 05, 2025 17:46 JST
Toyota Powers On New North Carolina Automotive Battery Plant
Feb 05, 2025 13:59 JST
Toyota to Form Comprehensive Partnership on Carbon Neutrality with Shanghai and Establish a Company to Develop and Produce BEVs and Batteries
Feb 05, 2025 13:56 JST
Fujitsu to highlight AI-powered network technologies at MWC Barcelona 2025
Feb 05, 2025 10:25 JST
TOYOTA GAZOO Racing Launches Evolved GR Corolla in Japan
Feb 04, 2025 18:41 JST
More Latest Release >>
Related Release
Alset International Ltd establishes Alset Mining Pte Ltd to embark on cryptocurrency mining activities
March 23 2022 09:00 JST
Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
February 21 2022 12:00 JST
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc.
October 05 2020 15:25 JST
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
September 18 2020 17:00 JST
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development
July 31 2020 15:00 JST
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance
June 24 2020 14:00 JST
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal
June 17 2020 18:00 JST
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
June 01 2020 13:00 JST
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts
April 24 2020 10:00 JST
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak
March 18 2020 11:00 JST
More Press release >>